BioSpace News Archive

AbbVie and the Keck Graduate Institute (KGI) School of Pharmacy have partnered to form the first AbbVie-KGI Biopharmaceutical Industry Fellowship.

About 1 in 2 colorectal cancers in Canada are diagnosed after they have spread to lymph nodes or other parts of the body, even though most provinces and territories have screening programs designed to catch the disease early or before it starts, according to a new report released today by the Canadian Cancer Society (CCS).

Newron Pharmaceuticals S.p.A. announces that the STARS clinical study (Sarizotan Treatment of Apneas in Rett Syndrome) in patients with Rett syndrome is expected to complete enrollment in H2 2018.

Maxar Technologies announced that Maxar President and CEO Howard Lance will be holding one-on-one and group meetings with investors, as well as participating in a panel discussion on “The Evolution of Commercial Space” at the Melius Research Industrial Tech & Aerospace Forum

RegeneRx Biopharmaceuticals, Inc. today held its 2018 Annual Meeting.

Today, your doctor is likely to be a “stranger at the bedside,” making decisions according to the “new morality” of bioethics, rather than the traditional Oath of Hippocrates, writes Jeffrey Hall Dobken, M.D., M.P.H., in the summer issue of the Journal of American Physicians and Surgeons. Dr. Dobken writes from the perspective of a doctor who is also a patient with a terminal disease.

Pharmacolog AB and HelioMetrics announced a new partnership that will deliver solutions designed to stop drug diversion and provide safe administration of IV medications for hospitals and pharmacies in the United States.

Noted as “Unmatched Leader,” Firm Earns Seventh Consecutive Tier 1 Health Care Accolade; Continues Rankings Streak

The Optical Society (OSA) Board of Directors is pleased to announce the approval of 169 new Senior Members

American Healthcare Investors and Griffin Capital Company, LLC announced that the REIT has entered into an agreement to acquire a portfolio of skilled nursing facilities located throughout the state of Missouri for $88.2 million.